Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

This study is currently recruiting participants.
Verified August 2012 by McGill University Health Center
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
CIHR Canadian HIV Trials Network
Information provided by (Responsible Party):
Marina Klein, McGill University Health Center
ClinicalTrials.gov Identifier:
NCT01231685
First received: October 29, 2010
Last updated: August 15, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)